NSCLC: Influence of Nivolumab plus Ipilimumab on Long-Term Overall survival

被引：0
|
作者：
Manych, Matthias
机构：
来源：
PNEUMOLOGIE | 2020年 / 74卷 / 03期
关键词：
D O I：
10.1055/a-1078-5162
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：130 / 130
页数：1
相关论文
共 50 条
  • [41] Long-term patient survival: Strategies to improve overall health
    Adams, PL
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2006, 47 (04) : S65 - S85
  • [42] Survival of responders to nivolumab (NIVO) plus ipilimumab (IPI) as first-line treatment for advanced NSCLC in CheckMate 227, part 1
    Brahmer, J. R.
    Ciuleanu, T-E.
    Schenker, M.
    Audigier-Valette, C.
    Zurawski, B.
    Linardou, H.
    Kim, S-W.
    Otterson, G. A.
    Salman, P.
    De La Mora Jimenez, E.
    Lesniewski-Kmak, K.
    Ahmed, S.
    Albert, I.
    Barlesi, F.
    Feeney, K.
    Frickhofen, N.
    Li, A.
    Sun, P.
    Hellmann, M.
    ANNALS OF ONCOLOGY, 2020, 31 : S1444 - S1445
  • [43] Long-term outcomes with nivolumab plus ipilimumab versus sunitinib in first-line treatment of patients with advanced sarcomatoid renal cell carcinoma
    Rini, Brian, I
    Signoretti, Sabina
    Choueiri, Toni K.
    McDermott, David F.
    Motzer, Robert J.
    George, Saby
    Powles, Thomas
    Donskov, Frede
    Tykodi, Scott S.
    Pal, Sumanta K.
    Gupta, Saurabh
    Lee, Chung-Wei
    Jiang, Ruiyun
    Tannir, Nizar M.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (12)
  • [44] Nivolumab (NIVO) Plus Low-Dose Ipilimumab (IPI) as First-Line (1L) Treatment (tx) of Advanced Nsclc: Overall Survival (Os) Analysis of Checkmate 817
    Fischer, Juergen R.
    Barlesi, Fabrice
    Audigier-Valette, Larisse
    Felip, Enriqueta
    Ciuleanu, Tudor-Eliade
    Jao, Kevin
    Rijavec, Erika
    Urban, Laszlo
    Aucoin, Jean-Sebastien
    Zannori, Cristina
    Vermaelen, Karim
    Aren Frontera, Osvaldo
    Ready, Neal
    Fontecedro, Alessandra Curioni
    Linardou, Helena
    Poddubskaya, Elena
    Pillai, Rathi
    Li, Sunney
    Acevedo, Angelic
    Paz-Ares, Luis
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 236 - 236
  • [45] LONG-TERM SURVIVAL OF PATIENTS WITH ADVANCED MELANOMA TREATED SECOND LINE WITH IPILIMUMAB
    Lee, D.
    Pericleous, L.
    Lebmeier, M.
    Winn, B.
    Batty, A.
    Nikoglou, T.
    ANNALS OF ONCOLOGY, 2012, 23 : 370 - 370
  • [46] The impact of long-term survival on treatment cost per month with ipilimumab (IPI)
    Bilir, Pinar
    Tarhini, Ahmad A.
    Li, Humin
    Barzey, Victor
    Bolinder, Bjorn
    Rao, Sumati
    Munakata, Julie
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [47] Serum protein predictors of long term survival from combined ipilimumab and nivolumab therapy in metastatic melanoma patients
    Homicsko, Krisztian
    Cuendet, Michel A.
    Michielin, Olivier
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [48] Influence of fenestration on long-term Fontan survival
    Materna, Ondrej
    Illinger, Vojtech
    Jicinska, Denisa
    Koubsky, Karel
    Kovanda, Jan
    Lozek, Miroslav
    Tax, Petr
    Reich, Oleg
    Chaloupecky, Vaclav
    Janousek, Jan
    CARDIOLOGY IN THE YOUNG, 2022, 32 (07) : 1021 - 1026
  • [49] Association between tumor shrinkage and overall survival in advanced melanoma patients with nivolumab in combination with ipilimumab
    Feng, Yan
    Gupta, Manish
    Agrawal, Shruti
    Roy, Amit
    CANCER RESEARCH, 2015, 75
  • [50] Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma (vol 377, pg 1345, 2017)
    Larkin, J.
    Chiarion-Sileni, V.
    Gonzalez, R.
    Grob, J. J.
    Cowey, C. L.
    Lao, C. D.
    Schadendorf, D.
    Dummer, R.
    Smylie, M.
    Rutkowski, P.
    Ferrucci, P. F.
    Hill, A.
    Wagstaff, J.
    Carlino, M. S.
    Haanen, J. B.
    Maio, M.
    Marquez-Rodas, I.
    McArthur, G. A.
    Ascierto, P. A.
    Long, G. V.
    Callahan, M. K.
    Postow, M. A.
    Grossmann, K.
    Sznol, M.
    Dreno, B.
    Bastholt, L.
    Yang, A.
    Rollin, L. M.
    Horak, C.
    Hodi, F. S.
    Wolchok, J. D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (22): : 2185 - 2185
12345